198 related articles for article (PubMed ID: 36290802)
21. Intravitreal connective tissue growth factor neutralizing antibody or bevacizumab alone or in combination for prevention of proliferative vitreoretinopathy in an experimental model.
Daftarian N; Baigy O; Suri F; Kanavi MR; Balagholi S; Afsar Aski S; Moghaddasi A; Nourinia R; Abtahi SH; Ahmadieh H
Exp Eye Res; 2021 Jul; 208():108622. PubMed ID: 34022176
[TBL] [Abstract][Full Text] [Related]
22. DAPL1 prevents epithelial-mesenchymal transition in the retinal pigment epithelium and experimental proliferative vitreoretinopathy.
Ma X; Han S; Liu Y; Chen Y; Li P; Liu X; Chang L; Chen YA; Chen F; Hou Q; Hou L
Cell Death Dis; 2023 Feb; 14(2):158. PubMed ID: 36841807
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of RPE senescence and potential role of αB crystallin peptide as a senolytic agent in experimental AMD.
Sreekumar PG; Reddy ST; Hinton DR; Kannan R
Exp Eye Res; 2022 Feb; 215():108918. PubMed ID: 34986369
[TBL] [Abstract][Full Text] [Related]
24. Complement activation contributes to subretinal fibrosis through the induction of epithelial-to-mesenchymal transition (EMT) in retinal pigment epithelial cells.
Llorián-Salvador M; Byrne EM; Szczepan M; Little K; Chen M; Xu H
J Neuroinflammation; 2022 Jul; 19(1):182. PubMed ID: 35831910
[TBL] [Abstract][Full Text] [Related]
25. Substance P prevents development of proliferative vitreoretinopathy in mice by modulating TNF-α.
Yoo K; Son BK; Kim S; Son Y; Yu SY; Hong HS
Mol Vis; 2017; 23():933-943. PubMed ID: 29296073
[TBL] [Abstract][Full Text] [Related]
26. miR-194 suppresses epithelial-mesenchymal transition of retinal pigment epithelial cells by directly targeting ZEB1.
Cui L; Lyu Y; Jin X; Wang Y; Li X; Wang J; Zhang J; Deng Z; Yang N; Zheng Z; Guo Y; Wang C; Mao R; Xu J; Gao F; Jin C; Zhang J; Tian H; Xu GT; Lu L
Ann Transl Med; 2019 Dec; 7(23):751. PubMed ID: 32042767
[TBL] [Abstract][Full Text] [Related]
27. Intravitreous Delivery of Αb-Crystallin Ameliorates N-Methyl-N-Nitrosourea Induced Photoreceptor Degeneration in Mice: An in vivo and ex vivo Study.
Tao Y; Ding L; Yao A; Yang Z; Yang Q; Qin L; Yu L; Gao Y; Huang YF; Li Z; Teng D
Cell Physiol Biochem; 2018; 48(5):2147-2160. PubMed ID: 30110696
[TBL] [Abstract][Full Text] [Related]
28. Regulation of fibronectin-EDA through CTGF domain-specific interactions with TGFβ2 and its receptor TGFβRII.
Khankan R; Oliver N; He S; Ryan SJ; Hinton DR
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5068-78. PubMed ID: 21571675
[TBL] [Abstract][Full Text] [Related]
29. Thrombin induces epithelial-mesenchymal transition and collagen production by retinal pigment epithelial cells via autocrine PDGF-receptor signaling.
Bastiaans J; van Meurs JC; van Holten-Neelen C; Nagtzaam NM; van Hagen PM; Chambers RC; Hooijkaas H; Dik WA
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8306-14. PubMed ID: 24302586
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA ERLR mediates epithelial-mesenchymal transition of retinal pigment epithelial cells and promotes experimental proliferative vitreoretinopathy.
Yang S; Li H; Yao H; Zhang Y; Bao H; Wu L; Zhang C; Li M; Feng L; Zhang J; Zheng Z; Xu G; Wang F
Cell Death Differ; 2021 Aug; 28(8):2351-2366. PubMed ID: 33664479
[TBL] [Abstract][Full Text] [Related]
31. Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model.
Heffer AM; Wang V; Libby RT; Feldon SE; Woeller CF; Kuriyan AE
PLoS One; 2020; 15(12):e0243626. PubMed ID: 33347461
[TBL] [Abstract][Full Text] [Related]
32. Divergent Metabolomic Signatures of TGFβ2 and TNFα in the Induction of Retinal Epithelial-Mesenchymal Transition.
Ng PQ; Saint-Geniez M; Kim LA; Shu DY
Metabolites; 2023 Jan; 13(2):. PubMed ID: 36837832
[TBL] [Abstract][Full Text] [Related]
33. Differentially expressed microRNAs in TGFβ2-induced epithelial-mesenchymal transition in retinal pigment epithelium cells.
Chen X; Ye S; Xiao W; Luo L; Liu Y
Int J Mol Med; 2014 May; 33(5):1195-200. PubMed ID: 24604358
[TBL] [Abstract][Full Text] [Related]
34. Silibinin Prevents TGFβ-Induced EMT of RPE in Proliferative Vitreoretinopathy by Inhibiting Stat3 and Smad3 Phosphorylation.
Ma X; Xie Y; Gong Y; Hu C; Qiu K; Yang Y; Shen H; Zhou X; Long C; Lin X
Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):47. PubMed ID: 37906058
[TBL] [Abstract][Full Text] [Related]
35. KRT8 phosphorylation regulates the epithelial-mesenchymal transition in retinal pigment epithelial cells through autophagy modulation.
Miao Q; Xu Y; Yin H; Zhang H; Ye J
J Cell Mol Med; 2020 Mar; 24(5):3217-3228. PubMed ID: 32022439
[TBL] [Abstract][Full Text] [Related]
36. Luteolin inhibits subretinal fibrosis and epithelial-mesenchymal transition in laser-induced mouse model via suppression of Smad2/3 and YAP signaling.
Zhang C; Zhang Y; Hu X; Zhao Z; Chen Z; Wang X; Zhang Z; Jin H; Zhang J
Phytomedicine; 2023 Jul; 116():154865. PubMed ID: 37201365
[TBL] [Abstract][Full Text] [Related]
37. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro.
Yao H; Ge T; Zhang Y; Li M; Yang S; Li H; Wang F
FASEB J; 2019 Mar; 33(3):3212-3224. PubMed ID: 30383450
[TBL] [Abstract][Full Text] [Related]
38. αB-Crystallin Regulates Subretinal Fibrosis by Modulation of Epithelial-Mesenchymal Transition.
Ishikawa K; Sreekumar PG; Spee C; Nazari H; Zhu D; Kannan R; Hinton DR
Am J Pathol; 2016 Apr; 186(4):859-73. PubMed ID: 26878210
[TBL] [Abstract][Full Text] [Related]
39. Polarity and epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy.
Zou H; Shan C; Ma L; Liu J; Yang N; Zhao J
PeerJ; 2020; 8():e10136. PubMed ID: 33150072
[TBL] [Abstract][Full Text] [Related]
40. A Mouse Model of Proliferative Vitreoretinopathy Induced by Intravitreal Injection of Gas and RPE Cells.
Heffer A; Wang V; Sridhar J; Feldon SE; Libby RT; Woeller CF; Kuriyan AE
Transl Vis Sci Technol; 2020 Jun; 9(7):9. PubMed ID: 32832216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
